Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PDSB/Capital expenditures

PDS Biotechnology Corporation (PDSB) Capital expenditures 2016–2025

PDS Biotechnology Corporation (PDSB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$0FY2025 · since FY2016: $686,705 → $0
161718232425
Fiscal yearValueYoY
FY2025$0-100.0%
FY2024$29,000—
FY2023$0—
FY2018$0-100.0%
FY2017$188,721-72.5%
FY2016$686,705—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More PDSB financial trends

PDSB RevenuePDSB Net incomePDSB Net marginPDSB Gross profitPDSB Gross marginPDSB Operating incomePDSB Operating marginPDSB Operating cash flowPDSB Free cash flowPDSB Return on equityPDSB Stock buybacksPDSB Dividends paidPDSB Total assetsPDSB Total liabilitiesPDSB Shareholders’ equityPDSB overview →